BriaCell Therapeutics Corp. (BCTX) vs Elicio Therapeutics, Inc. (ELTX)
A side-by-side comparison of BriaCell Therapeutics Corp. and Elicio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCTX
BriaCell Therapeutics Corp.
$4.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ELTX
Elicio Therapeutics, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCTX vs ELTX
growth of $100 · dividends reinvested · last 3yBCTX -99.3% (-80.9%/yr)ELTX -67.4% (-31.2%/yr)ELTX compounded faster over this window
Log scale — wide-divergence pair
BCTX ELTX
BCTX vs ELTX: by the numbers
- •ELTX is the larger company ($36M vs $35M market cap).
Metrics side by side
Valuation
| Metric | BCTX | ELTX |
|---|---|---|
| P/B ratio | 1.45 | 4.52 |
Profitability
| Metric | BCTX | ELTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -154.06% | -476.77% |
| ROIC | -164.58% | -171.36% |
Growth (annualized)
| Metric | BCTX | ELTX |
|---|---|---|
| Total return CAGR (5Y) | -67.32% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.